ESPRO® Awarded New Patent, Files Expanded Complaint Against Simpli Press
May21

ESPRO® Awarded New Patent, Files Expanded Complaint Against Simpli Press

Leading French press brand expands infringement suit after being issued a second patent on its technology ESPRO® Inc., creators of award-winning French presses and brewing accessories that simply “Make it Better,” has been awarded a second US patent on its industry-leading French press technology. Additionally, the brand yesterday filed an amended complaint against Made Simpli LLC, the makers of Simpli Press, for alleged patent...

Read More
Dotcom’s mega battle returns to court
May21

Dotcom’s mega battle returns to court

Lawyers for Kim Dotcom’s associates say the judge who cleared their extradition to the US never gave them a fair hearing and the whole process was “off the rails”. The 42-year-old tech entrepreneur and his three co-accused – Mathias Ortmann, Finn Batato and Bram van der Kolk – on Monday began an appeal against a ruling last year that there was “overwhelming” evidence they had criminal charges...

Read More
How Exactly is Instagram’s Snapchat-Like Stories Feature Legal?
May21

How Exactly is Instagram’s Snapchat-Like Stories Feature Legal?

Since the recent launch of Instagram “Stories” earlier this month, much of the discussion about the new feature has revolved around its nature of being a “blatant rip-off” of Snapchat’s own Stories capability. As you may know, Snapchat introduced its “Stories” in 2013, a feature that enables users to group snapshots into one cohesive narrative that disappears after 24 hours. On Tuesday, Instagram introduced its own Stories features,...

Read More
AbbVie files patent suit against Amgen
May21

AbbVie files patent suit against Amgen

Drugmaker AbbVie Inc. has filed a patent-infringement lawsuit against rival Amgen Inc. seeking to halt looming sales of a lower-priced replica of AbbVie’s top-selling drug, Humira. The lawsuit, filed late Thursday in federal court in Delaware, alleges Amgen’s copy of Humira violates many of AbbVie’s patents on the anti-inflammatory treatment. The suit asks the court to block any sales. Humira accounts for about 60%...

Read More
E-commerce helping easy availability of pharma drugs and abuse
May21

E-commerce helping easy availability of pharma drugs and abuse

Many of these pharmaceutical drugs are easily available over the counter and this has become the major factor that encourages their misuse. Growing e-commerce in India is facilitating significant increase in online pharmacies, leading to easy availability of pharmaceutical drugs and their abuse, the Narcotics Control Bureau (NCB) says. In its annual report for 2015, published on Friday, the NCB says abuse of pharmaceutical drugs in...

Read More